$GTI
GRAPHJET TECHNOLOGY Stock $gti

$gti Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224015564 Filed on April 22, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.000K
YoY Change
% of Gross Profit
Operating Expenses		$498.5K	$904.8K
YoY Change		-33.59%	-30.12%
Operating Profit	-$2.133M		-$904.8K
YoY Change	6638.7%		-30.12%
Interest Expense	$6.000K	$181.7K	$858.4K
YoY Change	-97.5%	-72.15%	-36.35%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.139M	-$316.9K	-$46.40K
YoY Change	-1118.57%	222.45%	-186.12%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.139M	-$316.8K	-$46.37K
YoY Change	-1117.91%	222.39%	-186.05%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.07	-$0.01
COMMON SHARES
Basic Shares Outstanding	144.6M shares
Diluted Shares Outstanding	146.7M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$6.000K	$6.000K
YoY Change		-87.45%	-87.45%
Cash & Equivalents	$88.00K	$5.503K
Short-Term Investments
Other Short-Term Assets	$104.0K	$18.00K	$18.00K
YoY Change	4.0%	-87.42%	-87.42%
Inventory
Prepaid Expenses	$60.00K	$18.06K
Receivables
Other Receivables
Total Short-Term Assets	$423.0K	$26.56K	$27.00K
YoY Change	242.12%	-92.65%	-92.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.270M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$13.96M	$13.96M
YoY Change		-28.55%	-28.55%
Other Assets
YoY Change
Total Long-Term Assets	$6.773M	$13.96M	$13.96M
YoY Change	-67.23%	-28.55%	-28.55%
TOTAL ASSETS
Total Short-Term Assets	$423.0K	$26.56K	$27.00K
Total Long-Term Assets	$6.773M	$13.96M	$13.96M
Total Assets	$7.196M	$13.99M	$13.99M
YoY Change	-65.39%	-29.71%	-29.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$711.0K	$952.1K	$952.0K
YoY Change	16.96%	38.76%	38.74%
Deferred Revenue
YoY Change
Short-Term Debt		$1.485M	$1.485M
YoY Change		473.05%	473.05%
Long-Term Debt Due	$528.0K
YoY Change
Total Short-Term Liabilities	$2.477M	$2.697M	$2.697M
YoY Change	38.5%	148.47%	148.5%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$4.025M	$4.025M
YoY Change		0.0%	0.0%
Total Long-Term Liabilities	$12.41M	$4.025M	$4.025M
YoY Change	210.15%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.477M	$2.697M	$2.697M
Total Long-Term Liabilities	$12.41M	$4.025M	$4.025M
Total Liabilities	$14.88M	$6.722M	$6.722M
YoY Change	156.01%	31.53%	31.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.41M	-$6.696M
YoY Change	206.02%	36.09%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.687M	-$6.695M	$7.264M
YoY Change
Total Liabilities & Shareholders Equity	$7.196M	$13.99M	$13.99M
YoY Change	-65.39%	-29.71%	-29.71%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.139M	-$316.8K	-$46.37K
YoY Change	-1117.91%	222.39%	-186.05%
Depreciation, Depletion And Amortization	$2.000K
YoY Change
Cash From Operating Activities		-$101.4K	-$396.8K
YoY Change		2678.08%	-40.59%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$164.3K	$6.606M
YoY Change
Cash From Investing Activities		-$164.3K	$6.606M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		184.3K	-$6.251M
YoY Change
NET CHANGE
Cash From Operating Activities		-101.4K	-$396.8K
Cash From Investing Activities		-164.3K	$6.606M
Cash From Financing Activities		184.3K	-$6.251M
Net Change In Cash		-81.40K	-$42.29K
YoY Change		2130.14%	-93.67%
FREE CASH FLOW
Cash From Operating Activities		-$101.4K	-$396.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2022Q4	ENCP	Working Capital Loan WorkingCapitalLoan		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables		usd
CY2022	ENCP	Cash Withdrawal From Trust Account In Connection With Redemption CashWithdrawalFromTrustAccountInConnectionWithRedemption		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	ENCP	Extension Loan Receivable ExtensionLoanReceivable		usd
CY2023	ENCP	Temporary Equity Extension Fund In Transit TemporaryEquityExtensionFundInTransit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41070
CY2023	dei	Entity Registrant Name EntityRegistrantName	GRAPHJET TECHNOLOGY
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit No. L4-E-8, Enterprise 4
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Technology Park Malaysia
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Bukit Jalil
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2023	dei	Entity Address Country EntityAddressCountry	MY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	57000
CY2023	dei	City Area Code CityAreaCode	018
CY2023	dei	Local Phone Number LocalPhoneNumber	272 7799
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	20700000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	144559578	shares
CY2023	dei	Auditor Name AuditorName	Adeptus Partners, LLC
CY2023	dei	Auditor Location AuditorLocation	Ocean, New Jersey
CY2023	dei	Auditor Firm AuditorFirmId	3686
CY2023Q4	us-gaap	Cash Cash	5503	usd
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18056	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	143055	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	3000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	170594	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	26559	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	361438	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	13959133	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	19535946	usd
CY2023Q4	us-gaap	Assets Assets	13985692	usd
CY2022Q4	us-gaap	Assets Assets	19897384	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	952142	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	686195	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	260000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	140000	usd
CY2023Q4	ENCP	Working Capital Loan WorkingCapitalLoan	354557	usd
CY2023Q4	ENCP	Extension Loan ExtensionLoan	1041480	usd
CY2022Q4	ENCP	Extension Loan ExtensionLoan	170594	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2696721	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1085331	usd
CY2023Q4	ENCP	Deferred Underwriting Commission DeferredUnderwritingCommission	4025000	usd
CY2022Q4	ENCP	Deferred Underwriting Commission DeferredUnderwritingCommission	4025000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	6721721	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5110331	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	13959133	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	19706540	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6695503	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4919828	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6695162	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13985692	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19897384	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	904790	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1294712	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-904790	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1294712	usd
CY2023	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	858423	usd
CY2022	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	1348596	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-46367	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53884	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2023Q1	us-gaap	Share Price SharePrice	0.045
CY2023Q1	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-255889	usd
CY2023Q1	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-210161	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16762	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5402299	usd
CY2023Q2	us-gaap	Share Price SharePrice	0.045
CY2023Q2	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-255889	usd
CY2023Q2	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-241790	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	210137	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5689841	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.045
CY2023Q3	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-194821	usd
CY2023Q3	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-224771	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	77106	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-6032327	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.045
CY2023Q4	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-164286	usd
CY2023Q4	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-181701	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-316848	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6695162	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3452832	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-59400	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3512232	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12989	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3525221	usd
CY2022Q3	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-697529	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	224556	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3998194	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3998194	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.045
CY2022Q4	ENCP	Stock Issued During Period Value Additional Amount Deposited Into Trust StockIssuedDuringPeriodValueAdditionalAmountDepositedIntoTrust	-652417	usd
CY2022Q4	ENCP	Remeasurement Ordinary Share To Redemption Amount RemeasurementOrdinaryShareToRedemptionAmount	-170594	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-98282	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-98282	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4919487	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-46367	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	53884	usd
CY2023	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	858423	usd
CY2022	us-gaap	Interest Income Debt Securities Available For Sale Operating InterestIncomeDebtSecuritiesAvailableForSaleOperating	1348596	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-125000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	135550	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	265947	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	642324	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	120000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	120000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	3000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-396843	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-667938	usd
CY2023	ENCP	Cash Withdrawal From Trust Account In Connection With Redemption CashWithdrawalFromTrustAccountInConnectionWithRedemption	7476716	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	870886	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6605830	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	870886	usd
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	354557	usd
CY2023	ENCP	Redemption Of Ordinary Shares RedemptionOfOrdinaryShares	7476716	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6251273	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42286	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-667938	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47789	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	715727	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5503	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47789	usd
CY2022	ENCP	Extension Loan Receivable ExtensionLoanReceivable	170594	usd
CY2023	ENCP	Value Of Class Ordinary Shares Subject To Redemption ValueOfClassOrdinarySharesSubjectToRedemption	13959133	usd
CY2022	ENCP	Value Of Class Ordinary Shares Subject To Redemption ValueOfClassOrdinarySharesSubjectToRedemption	19535946	usd
CY2023	ENCP	Remeasurement For Ordinary Share To Redemption Amount RemeasurementForOrdinaryShareToRedemptionAmount	858423	usd
CY2022	ENCP	Remeasurement For Ordinary Share To Redemption Amount RemeasurementForOrdinaryShareToRedemptionAmount	1349946	usd
CY2021Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	116725000	usd
CY2023Q4	us-gaap	Cash Cash	5503	usd
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2023Q4	ENCP	Working Capital WorkingCapital	2673162	usd
CY2022Q4	ENCP	Working Capital WorkingCapital	723893	usd
CY2023Q4	ENCP	Percentage Of Minimum Fair Market Value Of Net Asset Held In Trust Account PercentageOfMinimumFairMarketValueOfNetAssetHeldInTrustAccount	0.80	pure
CY2023Q4	ENCP	Minimum Post Business Combination Ownership MinimumPostBusinessCombinationOwnership	0.50	pure
CY2023Q4	ENCP	Redeeming Shares More Than Aggregate Percentage RedeemingSharesMoreThanAggregatePercentage	0.20	pure
CY2023Q4	ENCP	Redemptions In Connection With Business Combination To Redeem Percentage RedemptionsInConnectionWithBusinessCombinationToRedeemPercentage	1	pure
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	9604519	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	98062139	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2023Q4	us-gaap	Cash Cash	5503	usd
CY2022Q4	us-gaap	Cash Cash	47789	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2023Q4	ENCP	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	354557	usd
CY2022Q4	ENCP	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zdKpiqUmnZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z8nUW4y6nUVf">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	13959133	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	19706540	usd
CY2023Q4	ENCP	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	354557	usd
CY2022Q4	ENCP	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	5000001	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	19706540	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	116725000	usd
CY2023	ENCP	Temporary Equity Redemption Of Class Common Stock Including Interest TemporaryEquityRedemptionOfClassCommonStockIncludingInterest	-7476715	usd
CY2022	ENCP	Temporary Equity Redemption Of Class Common Stock Including Interest TemporaryEquityRedemptionOfClassCommonStockIncludingInterest	-98539000	usd
CY2022	ENCP	Temporary Equity Extension Fund In Transit TemporaryEquityExtensionFundInTransit	170594	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1729308	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1349946	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	13959133	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	19706540	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zVWsmvt2zQPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_869_zbIIsOxJtoKh">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments that potentially subject to concentration of credit risk consist of cash and cash held in trust. Cash is comprised of cash balances with banks and bank deposits, which are insured by the Federal Deposit Insurance Company (“FDIC”), up to $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20231231_znINB2cVouV" title="Federal depository insurance coverage amount">250,000</span>. The Company did not have cash exceed FDIC limits at December 31, 2023 and 2022. Cash held in trust is comprised of securities held by a financial institution, which are insured by the Securities Investor Protection Corporation (“SIPC”), comprised of $<span id="xdx_904_eus-gaap--Cash_iI_c20231231__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_z4LkDLj2NVz7" title="Cash coverage">250,000</span> coverage for cash and $<span id="xdx_90C_eus-gaap--MarketableSecurities_iI_c20231231__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_zZweN2PLrWph" title="Securities">250,000</span> for securities. The Company had $<span id="xdx_904_ecustom--SecuritiesInExcess_iI_c20231231__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_zJwtv2565LKh" title="Securities in excess">13,907,133</span> and $<span id="xdx_908_ecustom--SecuritiesInExcess_iI_c20221231__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_zeF96xGAJKai" title="Securities in excess">19,285,946</span> of securities in excess of SIPC limits as of December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.4pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	116725000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	111444250	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5280750	usd
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2862500	shares
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	The initial shareholders have agreed not to transfer, assign or sell any of the Class B ordinary shares (except to certain permitted transferees) until, with respect to 50% of the Class B ordinary shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the Class B ordinary shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	ENCP	Share Adjustment Description ShareAdjustmentDescription	the Company issues additional shares of Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial Business Combination on the date of the consummation of our initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

Files In Submission

Name	View Source	Status
0001493152-24-015564-index-headers.html	Edgar Link	pending
0001493152-24-015564-index.html	Edgar Link	pending
0001493152-24-015564.txt	Edgar Link	pending
0001493152-24-015564-xbrl.zip	Edgar Link	pending
aud_001.jpg	Edgar Link	pending
aud_002.jpg	Edgar Link	pending
encp-20231231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
encp-20231231_def.xml	Edgar Link	unprocessable
encp-20231231_lab.xml	Edgar Link	unprocessable
encp-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
encp-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTI
GRAPHJET TECHNOLOGY Stock $gti

2024 Q2 Form 10-K Financial Statement

#000149315224015564 Filed on April 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTI GRAPHJET TECHNOLOGY Stock $gti

2024 Q2 Form 10-K Financial Statement

#000149315224015564 Filed on April 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTI
GRAPHJET TECHNOLOGY Stock $gti